Suscribirse

Periprosthetic fracture in the elderly with anatomic modular cementless hemiarthroplasty - 20/09/16

Doi : 10.1016/j.otsr.2016.05.013 
P. Kouyoumdjian a, , A. Dhenin a, A. Dupeyron b, R. Coulomb a, G. Asencio a
a Service de chirurgie orthopédique et traumatologique, hôpital Carémeau, CHU de Nîmes, place de Pr-R.-Debré, 30000 Nîmes, France 
b Service de médecine physique et réadaptation, CHU de Nîmes, hôpital Carémeau, place de Pr-R.-Debré, 30000 Nîmes, France 

Corresponding author. Tel.: +33603998081; fax: +33466218057.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

The use of an anatomic cementless stem in hemiarthroplasties for femoral intracapsular proximal fracture has been debated, notably because of bone weakness and/or morphological defects related to osteoporosis. We therefore conducted a retrospective study in subjects over 75 years of age who had received an anatomic stem partially coated with hydroxyapatite. The objectives were to determine: 1) the incidence of periprosthetic fractures (PPFs) and, 2) the influence of anatomic factors, including the Cortical Bone Ratio (CBR) (the relation between the endosteal and external diameter of the femoral diaphysis 10cm below the lesser trochanter).

Hypothesis

The risk of PPF with an anatomic cementless implant is greater than with cemented stems.

Material and methods

We retrospectively analyzed 233 patients followed up for 5 years after their surgery. The stem used was an anatomic stem with a modular neck partially coated with hydroxyapatite. The risk factors examined were age, gender, history of osteoporotic fractures, diverse causes of secondary osteoporosis, and proximal bone stock according to various referenced radiological indices such as the CBR.

Results

Twenty patients (15%) were lost to follow-up, 74 had died (32%) but did not undergo revision for PPF, 15 of the 139 survivors at the last follow-up (10.8%) had had a PPF, five (3.6%; four females, one male) were early fractures (≤2 months after implantation), ten (7.2%; two females, eight males) were late fractures (>2 months). Male gender was protective for PPF occurrence (RR=0.129; 95%CI (0.04–0.39); P=0.0003), whereas secondary factors of osteoporosis (RR=2.035; 95%CI (1.11–3.72); P=0.0211), and CBR>0.49 (RR=227.42; 95%CI (1.072–48,226.76); P=0.0471) were found as risk factors of PPF.

Discussion

The PPF rate was greater than that related to cemented stems, requiring that morphological and clinical factors of bone weakness (collected with the patient history and related to osteoporosis) be taken into account. A CBR>0.49 requires caution on the use of this type of stem.

Level of evidence

Level 4. Retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Periprosthetic fracture, Hemiarthroplasty, Hip, Cementless stem, Osteoporosis


Esquema


© 2016  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 102 - N° 6

P. 701-705 - octobre 2016 Regresar al número
Artículo precedente Artículo precedente
  • Unstable intertrochanteric versus displaced femoral neck fractures treated with cementless bipolar hemiarthroplasty in elderly patients; a comparison of 80 matched patients
  • J.-D. Chang, I.-S. Kim, S.-S. Lee, J.-H. Yoo, J.-H. Hwang
| Artículo siguiente Artículo siguiente
  • Predictors of 30-day mortality following hip/pelvis fractures
  • A.C. Dodd, C. Bulka, A. Jahangir, H.R. Mir, W.T. Obremskey, M.K. Sethi

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.